Detection of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram Negative Bacteria Isolated from Intensive Care Unit-Khartoum-Sudan 2022
Keywords:
gram negative, carbapenemases, ESBL, ICU, MHTAbstract
Background: Carbapenemase are enzymes that are a major cause of bacterial resistance to the Carbapenem family of antibiotics such as meropenem. ESBL are derived from genes for narrow-spectrum beta-lactamase by mutations that alter the amino acid configuration around the enzyme active sites. Objective: The study aimed to detect the production of carbapenemases and Extended- spectrum beta-lactamase among Gram-negative bacteria isolated from Intensive Care Units (Alselah Hospital, Ribat University Hospital, and Sharg Elnile Hospital in Khartoum state, Sudan.).
Methodology: Descriptive cross-sectional facility-based study, conducted in Alselah Hospital, Ribat University Hospital, and Sharg Elnile Hospital in Khartoum state, Sudan, in which 100 gram negative bacteria were isolated from ICU (by simple random technique )in the period June to October 2022, and were investigated for susceptibility, phenotypic detection of carbapenemases and ESBL. The isolated bacteria were purified by subculture in MacConkey ager, colonial morphology, gram stain and set of biochemical tests were done and antimicrobial susceptibility test was performed by Carbapenem antibiotic family. Finally the phenotypic detection of carbapenemases was done by modified Hodge test, and then used double disk diffusion method to detect extended spectrum beta lactamase.
Result: One hundred isolates were investigated in this study, when susceptibility test was performed the highest susceptibility rate was registered for meropenem (84%) and the highest resistance rate for ceftriaxone (55%). ESBL producing bacteria were (16%) and Modified Hodge Test positive was (3%).
Conclusion: The findings revealed that there was a minimum rate of ESBLs and Carbapenemase producing gram negatives isolated from ICU.
References
1. Oliveira, J., & Reygaert, W. C. Gram negative bacteria. Statpearls publishing2019.
2. Rawat D, & Nair D. Extended- spectrum β-lactamases in Gram Negative Bacteria. Journal of global infectious diseases 2010,2:3, 26.
3. Paterson, D. L., & Bonomo, R. A. Extended-spectrum β-lactamases: a clinical update. Clinical microbiology reviews, (2005),18:4, 657-686.
4. Teklu D, Negeri A, Legese M, Bedada T, Woldemariam H, & Tullu K. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrobial Resistance & Infection Control 2019,8:1, 1-12.
5.Gladstone P, Rajendran P, & Brahmadathan K. Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian journal of medical microbiology, 2005,23:3, 189–191.
6. Amjad A, Mirza I, Abbasi S, Farwa U, Malik N, & Zia F. Modified Hodge test, A simple and effective test for detection of carbapenemase production. Iranian journal of microbiology 2011,3:4, 189–193.
7.Alemayehu T, Asnake S, Tadesse B, Azerefegn E, Mitiku E, Agegnehu A, & Nigussie N. Phenotypic detection of carbapenem-resistant gram- negative Bacilli from a clinical specimen in Sidama, Ethiopia. Infection and Drug Resistance 2021,14:369.
8. Basheer N, Yousif M, Nouraldayem H, & Elhag K. Molecular Characterization of Carbapenem Resistant Gram Negative Bacteria in Khartoum (Sudan). African Journal of Medical Sciences 2020,5:2.
9. Drieux L, Brossier F, Sougakoff W, & Jarlier V. Phenotypic detection of extended‐spectrum β‐lactamase production in Enterobacteriaceae, review and bench guide. Clinical Microbiology and Infection 2008,14, 90-103.
10. Mathlouthi N, Al-Bayssari C, El Salabi A, Bakour S, Ben Gwierif S, Zorgani A, Jridi Y, Ben Slama K, Rolain J, & Chouchani C. Carbapenemases and extended- spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals. The Journal of Infection in Developing Countries 2016,10:07, 718-727.
11. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in North India. Indian J Med Res 2006,124: 95.
12. Pena C, Ardanuy C, Ricart A, Pallares R. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum b- lactamases. Antimicro Agents Chemother 1998, 42:53 e8.
13. Alebel M, Mekonnen F, & Mulu W. Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram- Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital 2021,14:391–405.
14. Wattal C, Goel N, Oberoi J, Raveendran R, Datta S, Prasad K. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 2010,58:32‑6.
15. Jain A, Roy I, Gupta M, Kumar M, & Agarwal. Prevalence of extended- spectrum β-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. Journal of Medical Microbiolog2003,5:25, 421-425.
16. Lee W, Jung B, Hong S, Song W, Jeong H, Lee K, & Kwak S. Comparison of 3 phenotypic detection methods for identifying plasmid- mediated AmpC betalactamase- producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis strains. Korean J Lab Med 2009, 29:5, 448-54.
17. Pal N, Hooja S, Sharma R, & Maheshwari K. Phenotypic Detection and Antibiogram of β‑lactamase‑producing Proteus Species in a Tertiary Care Hospital, India. Annals of Medical and Health Sciences Research2016,6:5, 267-279.
18. Nageeb W, Kamel M, Zakaria S, & Metwally L. 2014, Phenotypic characterization of Acinetobacter baumannii isolates from intensive care units at a tertiary-care hospital in Egypt. EMHJ- Eastern Mediterranean Health Journal 2014,20:3, 203-211.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ahmed Emadeldin Osman, Alruomaisa Yousif Abker, Braah Mubarak Abdalraheem, Ezdehar Yousif Osman, Farida Farid Hamza, Saja Sulieman Nimir, Moil Babiker Alshiekh, Hiba Elrahman Fathelrahman Ahmed (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
NSJ is an open-access journal. All content is freely available under the Creative Commons Attribution 4.0 International License (CC BY 4.0)